KDM6A and breast cancer: The multitarget inhibitor MC3324 inhibited both LSD1 and UTX, resulting in significant growth arrest and apoptosis in hormone-responsive breast cancer models, while also causing robust increases in H3K4me2 and H3K27me3 [55].